| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CBDD.12721 |
| P8608 | Fatcat ID | release_df3y3vun2fhm3c6spcf7fpthzu |
| P698 | PubMed publication ID | 26802437 |
| P50 | author | Catherine Mollereau | Q59784775 |
| Santosh Pasha | Q96206628 | ||
| P2093 | author name string | Krishan Kumar | |
| Annu Mudgal | |||
| P2860 | cites work | Dynorphin-(1-13), an extraordinarily potent opioid peptide | Q24561638 |
| Receptor heteromerization and drug discovery | Q24631740 | ||
| G-protein-coupled receptor heteromers: function and ligand pharmacology | Q24653717 | ||
| Modulatory role of neuropeptide FF system in nociception and opiate analgesia | Q28248571 | ||
| Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity | Q28283440 | ||
| Modulatory roles of the NPFF system in pain mechanisms at the spinal level | Q28294362 | ||
| Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells | Q28299030 | ||
| Neuropeptide FF and modulation of pain | Q33804790 | ||
| Opioid-receptor-heteromer-specific trafficking and pharmacology | Q33978499 | ||
| RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia | Q34249621 | ||
| GPCR heteromers and their allosteric receptor-receptor interactions | Q34254454 | ||
| Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity | Q34354902 | ||
| Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1. | Q34559158 | ||
| In vivo opioid receptor heteromerization: where do we stand? | Q34939677 | ||
| Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile | Q34983352 | ||
| A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks | Q35123224 | ||
| Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice | Q35218957 | ||
| A review of the role of anti-opioid peptides in morphine tolerance and dependence | Q35275948 | ||
| Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments. | Q35708164 | ||
| Opioid-modulating peptides: mechanisms of action | Q36109084 | ||
| Peptide-membrane interactions and a new principle in quantitative structure-activity relationships | Q36435277 | ||
| Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine | Q37555862 | ||
| Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity | Q37562642 | ||
| Rational design of dualsteric GPCR ligands: quests and promise | Q37688232 | ||
| Opioid-modulating properties of the neuropeptide FF system | Q37783966 | ||
| Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors | Q38202835 | ||
| The action of FMRFamide (Phe-Met-Arg-Phe-NH2) and related peptides on mammals | Q39561814 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues | Q42132164 | ||
| Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. | Q42189140 | ||
| (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation | Q44106436 | ||
| Regional distribution of methionine-enkephalin-Arg6-Phe7 in the rat brain: comparative study with the distribution of other opioid peptides | Q44331210 | ||
| Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa. | Q44332093 | ||
| Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat. | Q44332311 | ||
| From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes | Q44335899 | ||
| Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors | Q44336906 | ||
| YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment | Q44337451 | ||
| Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine | Q44342198 | ||
| Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain | Q44345811 | ||
| Met-enkephalin-Arg6-Phe7, present in high amounts in brain of rat, cattle and man, is an opioid agonist | Q44352776 | ||
| FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. | Q45068435 | ||
| Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay | Q45168556 | ||
| Conformational analysis of dynorphin A (1-13) using hydrogen-deuterium exchange and tandem mass spectrometry | Q46640668 | ||
| FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence | Q48903032 | ||
| Basic concepts in G-protein-coupled receptor homo- and heterodimerization. | Q55136877 | ||
| P433 | issue | 6 | |
| P921 | main subject | enkephalin | Q325101 |
| P304 | page(s) | 885-894 | |
| P577 | publication date | 2016-01-23 | |
| P1433 | published in | Chemical Biology and Drug Design | Q15749458 |
| P1476 | title | NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia | |
| P478 | volume | 87 |
Search more.